anlotinib
ALTN-SCLC-001
Phase 2 small_molecule active
Quick answer
anlotinib for Extensive-stage Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Fudan University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fudan University
- Indication
- Extensive-stage Small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active